Bone marrow-derived mesenchymal stem cells (BM-MSCs) can be induced to differentiate into myogenic cells. Despite their potential, previous studies have not been successful in producing a high percentage of cardiac-like cells with a muscle phenotype. We hypothesized that cardiac lineage development in BM-MSC is related to cell passage, culture milieu, and enrichment for specific cell subtypes before and during differentiation. Our study demonstrated that Lin − BM-MSC at an intermediate passage (IP; P8-P12) expressed cardiac troponin T (cTnT) after 21 days in culture. Cardiac TnT expression was similar whether IP cells were differentiated in media containing 5-azacytidine + 2% FBS (AZA; 14%) or 2% FBS alone (LS; 12%) and both were significantly higher than AZA + 5% FBS. This expression was potentiated by first enriching for CD117/Sca-1 cells followed by differentiation (AZA, 39% and LS, 28%). A second sequential enrichment for the dihydropyridine receptor subunit α2δ1 (DHPR-α2) resulted in cardiac TnT expressed in 54% of cultured cells compared to 28% of cells after CD117/Sca-1 + enrichment. Cells enriched for CD117/Sca-1 and subjected to differentiation displayed spontaneous intracellular Ca 2+ transients with an increase in transient frequency and a 60% decrease in the transient duration amplitude between days 14 and 29. In conclusion, IP CD117/ Sca-1 + murine BM-MSCs display robust cardiac muscle lineage development that can be induced independent of AZA but is diminished under higher serum concentrations. Furthermore, temporal changes in calcium kinetics commensurate with increased cTnT expression suggest progressive maturation of a cardiac muscle lineage. Enrichment with CD117/Sca-1 to establish lineage commitment followed by DHPR-α2 in lineage developing cells may enhance the therapeutic potential of these cells for transplantation.
Introduction
Bone marrow-derived mesenchymal stem cells (BM-MSCs) exhibit neurogenic, chondrogenic, adipogenic, osteogenic, and myogenic properties under specific differentiating conditions in vitro. Although these cells have contributed to improvement in overall cardiac performance in studies of myocardial regeneration, the mechanisms responsible for their therapeutic effects are not well established. BM-MSCs are characterized as a small percent of lineage negative (Lin − ) adherent cells, and their myogenic lineage potential is highly dependent on the enrichment for specific markers following harvesting. Published results have shown that further enrichment of Lin − cells for the CD117 and Sca-1 membrane surface markers may improve BM-MSC ability to differentiate into cardiomyocytes [1] [2] [3] [4] [5] . Furthermore, cell surface markers such as CD117 change over time [2, 6] and from passage to passage in cultured cells. Thus, we hypothesize that in murine BM-MSC, differentiation into cardiomyocytes is dependent on cell passage and the potential for differentiation is greater in early passage cells (P ≤ 12) compared to late passage cells (P ≥ 20) . Previous studies indicate that there is no well-defined and consistent myogenic differentiation method. Some methods involve the use of 5-azacytidine (AZA), a methyltransferase inhibitor. Although this reagent induces myogenic development [7] [8] [9] , it has limited use in human cell therapy. Other differentiation protocols that induce myogenic commitment in BM-MSC include the use of TGF-beta [6] and neonatal or adult cardiomyocyte co-cultures [10] [11] [12] [13] . A recent report on human embryonic stem cells (hESC) demonstrated that hESC cardiomyocyte differentiation increased when the cells were cultured in serum-free media compared to 20% serum in the media [14] . Thus, we also propose to evaluate BM-MSC differentiation in low serum (LS) media and compare it to AZA treatment.
We demonstrate here for the first time that CD117/Sca-1 enrichment following passage 10 in Lin − murine BM-MSC results in increased sarcomeric protein expression and spontaneous calcium transients that change over time in culture when differentiated in low serum. Furthermore, we show that a subsequent second enrichment for the dihydropyridine receptor subunit α2δ1 (DHPR-α2) and cell replating induces a greater expression of cardiac TnT expression than with CD117/Sca-1 enrichment alone. Thus, we defined specific steps that allow an enhanced differentiation of BM-MSC into cardiomyocytes.
Materials and methods

Animals
Mice were housed in the Biological Resources Laboratory at UIC (AAALAC accredited) and maintained in accordance with the Guide for the Care and Use of Laboratory Animals (National Research Council, revised 1996). Experimental protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at UIC.
Bone marrow mesenchymal stem cell (BM-MSC) characterization and culture
Bone marrow was isolated from FVB.Cg-Tg(GFPu)5Nagy/J mice (Jackson Laboratory) as previously described [15] . Tibia and femur bones were stripped of muscle and placed in ice-cold PBS + 2% FBS. The epiphyseal ends were removed and the bones were centrifuged at 4000×g for 1 min in a microfuge tube. The bone marrow cells were suspended in ice-cold PBS + 2% FBS, passed through a 70-μm filter and counted with a hemocytometer.
Filtered bone marrow cells were suspended in PBS + 2% FBS + 0.1 g/L phenol red and enriched for lineage negative (Lin − ) cells using the SpinSep system (Stem Cell Technologies). The cells were incubated with Murine Progenitor Enrichment Cocktail (anti-CD5, anti-CD45R, anti-CD11b, anti-Gr-1, anti-TER119, and anti-7/4; Stem Cell Technologies) on ice for 30 min and, after washing, incubated with dense particles on ice for 20 min. The cells were layered on density medium, centrifuged at 1200×g for 10 min, and the layer of cells at the density medium/PBS interface was collected, washed, and counted.
Enriched bone marrow cells were seeded on tissue culture-treated plates at a density of 0.1 × 10 6 cells/cm 2 in murine Mesencult media (Stem Cell Technologies) with 100 U/ml penicillin, 100 μg/ml streptomycin, and 0.25 μg/ml amphotericin B added. The media were changed after 48 h and adherent cells were maintained in culture with twice weekly media changes. After 4 weeks the confluent cells were detached with trypsin and split 3:1. Lin − MSCs were characterized for surface antigens using flow cytometry. Antibodies were obtained from BD Pharmingen unless otherwise noted. Cultured cells were detached with trypsin and incubated with 1 μl mouse Fc block (1:50 dilution; clone 2.4G2, rat anti-mouse CD16/CD32) for 5 min on ice. Cells were then incubated with 1 μl fluorescent-conjugated antibodies (1:50 dilution) for 1 h on ice, washed, and analyzed. The following mouse monoclonal antibodies were used: anti-CD45-Cy5 (clone 30-F11), anti-Sca1-PE (clone E13-161.7), antiSca1-Cy5 (clone D7; eBioscience), anti-CD34-PE (clone RAM34), anti-CD90.1-PE (clone HIS51), anti-CD117(cKit)-PE (clone 2B8), anti-CD105-biotin (clone MJ7/18; eBioscience). Those treated with biotinylated antibodies were washed and incubated 20 min at room temperature with 1 μl streptavidin-PE or streptavidin-Cy5. Control samples were treated with immunoglobulin of the appropriate isotype. Cells were analyzed in a (FACS) Calibur flow cytometer or in a Beckman Coulter FC500 equipped with one (Calibur) or two lasers (Beckman) for multiparametric and multicolor analysis, including a 488-nm argon laser for measurement of forward light scatter (FSC) and orthogonal scatter (SSC), and three to five colors.
BM-MSC cardiomyocyte differentiation
BM-MSCs were plated (BD Falcon slides 354112 and Bioptech Tdish 0420041500B) at a density of 8000 cells per well for early passage cells (EP: P0-P2). All intermediate passages (IP: P8-P12) and late passage (LP: P20 and above) cells were plated at a density of 3000 cells per well (4 cm   2 ). Cells were allowed to attach to the plate by culturing them for 24 h in Mesencult with supplements. After adhering, cells were treated with one of five differentiating media for 19-21 days (Fig. S1 ). AZA-treated cells were cultured with 1.2 μM AZA in Eagle's MEM with 2% FBS for 72 h (Sigma: 5-azacytidine, A2385, MEM, M0643 with 2.2 g sodium bicarbonate Invitrogen: Certified Fetal Bovine Serum 16000-044). Low serum (LS)-treated cells were cultured in Eagle's MEM with 2% FBS for 72 h. Cells were also treated for 72 h with AZA alone and AZA with 5% serum. After 72 h, the media in the four AZA and/or LS groups were replaced every 2 to 3 days using MEM with 5% FBS and 5 μg/ml of insulin and transferrin, 5 ng/ml of sodium selenite (Sigma: ITS, I1884 prepared as recommended). A fifth group of cells was treated with MEM and 5% FBS for the entire 19-21 days. 
Immunofluorescent staining
Differentiated cells were stained for cardiac-specific Troponin T, cardiac isoform Ab-1 (cTnT; Thermo Scientific MS-295-P0). The cells were fixed with 2% paraformaldehyde for 20 min. We used horse serum (5%) diluted in 0.1% Tween in PBS for blocking and permeabilization for 45 min. Additional blocking with avidin and biotin agents (Vector Labs, SP2001) was performed for 15 min each. The primary cTnT was mixed with ready to use ultra Ab diluent (Thermo Scientific, TA-125-UD, in a ratio of 1:200) and incubated overnight at 4°C. Biotinylated horse anti-mouse IgG (Vector Labs BA-2001) was used as the secondary (1 h at RT, 1:250), and streptavidin Alexa Fluor 555 or 633 conjugate (Invitrogen: S21381, S21375,1:1000) was used for fluorescent detection (15 min at room temp). After washing, cells were mounted with DAPI (Vector Laboratories, Inc). For the isotype controls, we used IgG1 (R&D Systems: MAB 002, 1:200). For DHPR-α2 staining, we used the same procedure described above except that DHPR-α2 (ABR-Thermo Fisher: MA3-921, 1:300) was used as the primary antibody.
DHPR-α2 enrichment of differentiated cells
After 26 days in culture, differentiated cells were lifted from the plate with enzyme-free dissociation buffer (Gibco: 1752). Cells were washed and re-suspended in a buffer mixture of 50% MEM and 50% ) them for an additional 30 days. Thus, we could examine the effects of both length of time in culture and lifting/replating the cells on cTnT expression.
Intracellular calcium (Ca
2+ ) measurements
Differentiated cells plated in 0.17 mm thick Bioptechs Delta T dishes and incubated with MEM and 5% FBS media and a calciumsensitive dye (Fluo-4/AM, Invitrogen: F1420, 5 μM) .The dye was prepared by dissolving 50 μg of fluo-4/AM in 50 μl of DMSO and 50 μl of 20% Pluronic F-127 and 400 μl of Tyrode's salt solution [16] (Sigma: T2145, with 1 g of sodium bicarbonate and pH set to 7.4 for 15 min at room temperature). Thereafter, cells were washed and incubated with new MEM media and allowed to rest for 15 min for de-esterification of the dye. For viewing, the media was replaced with Tyrode's salt solution. Calcium cycling cells were identified and selected for line scan analysis (Zeiss LSM 510). The sampling time of the scan was between 3.7 and 7.8 ms per line depending on the cycling rate of the selected cell. Fluo-4/AM was excited at 488 nm and the emission was collected above 515 nm. The parameters extracted from the generated curves were (1 
cTnT-positive cell count and morphology
For positive cTnT cell count, fields of view within a slide were randomly selected throughout the slide where cells were present. Nucleus (DAPI staining) and cTnT (Alexa Fluor 555) images were taken for each field with a Sony camera (DSC-H9). All images were originally stored in bit map format and filtered utilizing ImageJ (NIH. gov) for cell counting. The percentage of cTnT-positive cells was obtained after comparing the number of positive cells with the number of nucleus in a field.
For area measurements, fields of view were randomly selected throughout the slide where cTnT-positive cells were present. Nuclei (DAPI staining) and cTnT (Alexa Fluor 633) images were taken for each field with a Zeiss confocal microscope with the cTnT color set to green. Only cells aligned with the surface of the focal plane (those having a defined nucleus) were measured. We used the analyze particles tool from ImageJ (NIH software) to measure the cell area. The average areas and the standard deviations at each of the time points measured were divided by the average area of cells at day 5 to compare cell area growth.
RT-PCR and cDNA sequencing
Total RNA was obtained from IP CD117/Sca-1-enriched cells differentiated in 2% FBS at days 5, 15, 20 and 26 and adult cardiac tissue using the Trizol® reagent (Gibco: No 15596) protocol for suspended cells (BM-MSCs) and tissue protocol for the adult heart. The RNA eluate was reverse transcribed using 5 μl of RNA and 200 U of M-MLV RT reverse transcriptase and random hexamers (Invitrogen: No 8080127). PCR was performed with Taq DNA Polymerase (Fermentas: No. EP0402) and gene-specific primers 18 to 27 nucleotides in length. The total PCR volume was 50 μl, with 1 μl of the amplified cDNA, 1× PCR buffer, 0.2 mM of dNTP, 2 mM of MgCl2, 2.5 U of Taq DNA polymerase, and 0.4 μM of primer (see sequences below). PCR products were sizefractionated by 2% agarose gel electrophoresis. The primer sequences were as follows: for DHPR-α2 (forward) GGC CGG ATC CGC AAT TGA TCC TAA TGG and (reverse) GAA GGC TGC AGA TCAT TGC AGT ATTC; for cTnT (forward) TGC ACT TTG GAG GGT ACATC and (reverse) GTC TTC ATT CAG GTG GTC GA; for cTnI (forward) GCT CCT CTG CCA ACT ACCGA and (reverse) CAA CGA GTC CTCA GAA CGCG; for GATA-4 (forward) GAA CCT GAA TAA ATC TAA GACGC and (reverse) TCT GAG TGA CAG GAG ATG CATA; and for GAPDH (forward) TAT GAC AAT GAA TAC GGCT and (reverse) CTC CTG TTA TTA TGG GGG. 
Statistical data analysis
Values are presented as means ± SEM and n is the number of experiments. The significant differences between groups were evaluated using SigmaStat (Systat Software Inc.). Groups with unequal variances were analyzed using the Kruskal-Wallis Test, and post hoc multiple comparisons between groups were performed with Dunn's method. For experiments where only two sets of data were compared, we used the Mann-Whitney rank sum test method. A result of p b 0.05 was considered statistically significant.
Results
BM-MSC flow cytometry and passage selection
In preparation for our experiments, MSCs were analyzed by flow cytometry for the presence of various surface antigens after negative lineage selection and following two different passages in culture. Negative selection for the lineage markers CD5, CD45R, CD11b, Gr-1, TER119, and 7/4 resulted in a cell population containing CD34 (3%), CD 90.1 (34%), CD105 (23%), CD117 (43%), and Sca-1 (21% To improve the percentage of cTnT-positive cells, we enriched IP cells for CD117/Sca-1 and used the five differentiation conditions described in the Materials and methods section (see also Fig. 1 provides a summary of the overall series of experiments performed based on cell passage and enrichment for CD117/Sca-1. Cell counts of microscopic fields of these differentiated cells revealed that the enriched cells had 39 ± 3% and 28 ± 2% cTnT-positive expression compared to the non-enriched control cells which had 14 ± 1% and 12 ± 2% after treatment with AZA and LS, respectively, as shown in Fig. 2 . A magnification of IP cTnT + cell staining is shown in Fig. S4 . Separately, IP CD117/Sca-1 + cells that were treated with control culture medium (MEM and 5% FBS) only exhibited 18 ± 3% cTnT-positive cells, significantly less than in AZA or LS-treated cultures (see Fig. S5 ). These results support the hypothesis that CD117/Sca-1 enrichment of murine BM-MSC increases their differentiation potential in specific media. The percent of cTnT + cells in the AZA + 0% and 5% FBS groups were expressed as a ratio of the AZA +2% FBS group used in our experiments. There was no difference between AZA with 0% FBS and AZA with 2% FBS. AZA with 5% FBS had a significantly lower ratio of cTnT + cells compared to the AZA +2% FBS group (Fig. S6) . Thus, we concluded AZA did not significantly improve cTnT expression compared to 2% FBS alone but that serum levels above 2% in the differentiating media significantly decreased the expression of cTnT. (10, 42) , (7, 27) , and (9, 76) for days 14, 19 , and 29, respectively. Cells used for line scan Ca 2+ transient measurements were fixed and stained for cTnT and when possible the same cell was identified on the slide for both measurements. Fig. 5 shows an example of a cell with spontaneous Ca 2+ transients stained positive for cTnT. These data support the hypothesis that spontaneous Ca 2+ oscillations originate from cells exhibiting a cardiac lineage.
Temporal changes in expression of cTnT and BM-MSC morphology
cTnT expression is enhanced after DHPR-α2 enrichment
DHPR-α2 is a membrane protein present in cardiac as well as skeletal and neuronal cells. The expression of L-type Ca 2+ channels is an early event in the development of cardiac myocytes [19] . To further increase the number of cTnT-positive cells in our in vitro differentiation studies, we proposed to include a DHPR-α2-positive selection step as a second enrichment process, thus eliminating most nonmyogenic cells. This step was performed at day 26, after the cells had differentiated into a cardiac muscle lineage (cTnT positive). illustrates the PCR results of the IP CD117/Sca-1-enriched cells during differentiation. These data demonstrate that amplicons for several cardiac-specific and developmental genes are observed during the early stage of differentiation. DHPR-α2 is also observed during differentiation and suggests that this transmembrane subunit of the L-type calcium channel is expressed commensurate with the cardiacspecific genes. We noted that there was a doublet amplicon for the DHPR-α2 subunit in our RT-PCR analysis. The primers used for the PCR did not distinguish between cardiac and skeletal muscle forms of the subunit suggesting that myogenic development for both skeletal and cardiac muscle probably occurred in our cultures. Fig. 6B shows the results of DHPR-α2 staining of CD117/Sca-1 + cells after 20 days in differentiating media and B shows the DHPR-α2 FACS analysis of CD117/Sca-1-enriched cells for the same time period. After having sorted the differentiated cells described in Fig. 6C , the cells were replated and cultured in MEM with 5% FBS and ITS, and the sorted cells recovered and easily adhered to the plate within the first 24 h.
These DHPR-α2-enriched cells were cultured for an additional 30 days and fixed for immunofluorescent cTnT staining (Fig. 6D) . Cell counts show that there was a significant increase in the percent of cTnT-positive cells 54 ± 3% (n = 45) for the DHPR-α2-enriched compared to 28 ± 2% (n = 33) in the CD117/Sca-1-enriched and 12 ± 2% (n = 46) in the control cells shown in Fig. 6E . Our control experiments (Fig. S7) show that if differentiated cells with 2% FBS are kept in culture for 56 days or if they are lifted at day 26 and replated for an additional 30 days, the level of cTnT expression is unchanged but is still significantly lower than the cTnT expression observed in DHPR-α2-enriched cells.
We observed spontaneous Ca 2+ oscillations in the DHPR-α2 + cells and were able to identify spontaneous Ca 2+ transients in cTnTpositive cells. It is interesting to note that we were able to observe spontaneous synchronized cycling and movement on some DHPR-α2 cultured plates 30 days after seeding. Supplemental Video 1 shows a group of differentiated DHPR-α2-enriched cells in motion and Overall the Ca 2+ transient duration compares well with those described for embryonic mouse cardiomyocytes [16] . Fluo-4/AMloaded DHPR-α2-enriched BM-MSCs were also electrically stimulated in culture and sequentially incubated with either 40 µM nifedipine to specifically block the L-type Ca 2+ channel or 100 µM cadmium to block calcium entry via both the L-type and T-type Ca 2+ channels. Our data demonstrate ( Fig. 8 and Supplemental Video 3) that some of the differentiated and enriched cells were sensitive to the addition of nifedipine, suggesting that BM-MSCs did develop functional L-type calcium channels while transients in other cells persisted. When exposed to cadmium, all fluo-4/AM generated calcium transients were abolished (Supplemental Video 4).
Discussion
We have demonstrated that cardiomyogenesis in adherent bone marrow-derived Lin − cells is greatly enhanced when differentiation is initiated in intermediate passage cells (P8-P12) in low serum following enrichment for the stem cell markers CD117/Sca-1. The percent of cells expressing cardiac-specific TnT was significantly elevated compared to those previously reported for bone marrowderived mesenchymal cells [20] . Most strikingly, a large number of these myogenic cells also displayed spontaneous calcium transients by day 12 in culture and reduced transient amplitude durations between days 14 and 29. This temporal change in calcium transients also correlated with the most significant changes in cell morphology (between days 15 and 21 in culture). CD117/Sca-1 + cells cultured in differentiating media also expressed DHPR-α2 by day 15. When these cells were further enriched for DHPR-α2 and re-seeded for an additional 30 days in culture, the percent of cells expressing cTnT doubled compared to CD117/Sca-1 + BM-MSC-enriched cells alone.
We observed that the number of cTnT + cells did not increase when we extended the time in culture for an additional 30 days without DHPR-α2 enrichment. Similarly, lifting and replating the cells for an additional 30 days in culture did not improve the expression of cTnT of CD117/Sca-1 + cells. Therefore, we conclude that further enrichment of cells for a muscle-specific protein (DHPR-α2) establishes a culture of highly differentiated cells that are more likely to exhibit a myogenic lineage. Previous studies demonstrate that induction of the myogenic program can be initiated in bone marrow-derived mesenchymal stem cells but this has been limited to changes in protein expression [6] [7] [8] [9] [20] [21] [22] [23] or studies in which expression of muscle-specific proteins in MSC have been induced by TGF-β [6] , Wnt-mediated signaling [20] , and co-culturing with cardiac myocytes [10] [11] [12] [13] 22] . The protocol in the present study included an enrichment step after Lin − BM-MSC were in culture for an extended period of time (P8-P12).
In contrast, enrichment for CD117/Sca-1 + at the time of bone marrow harvest results in a significant population of hematopoietic stem cells that have been shown to lack myogenic potential [24] [25] [26] . Furthermore, CD117 expression decreases over time and passage in culture [2, 6] due either to decreased expression of the receptor or loss of nonadherent cells with passage. We observed these same changes in both our EP and LP cells. EP cells did not adhere well to the culture plate containing our differentiation media and LP cells lost expression of CD117/Sca-1 over time. Thus, we cannot conclude from our experiments that passage number has an effect on the potential for CD117/ Sca-1 + cells to develop into a myogenic lineage.
Observations of differentiated cells revealed large growth areas with tubular-shaped cell formation and multi-nucleated cells together with large growth areas of non-myogenic cells. Thus, after testing for the presence of DHPR-α2 in the differentiated cultures, we reasoned that further enrichment for DHPR-α2 protein might produce cultures with higher myogenic potential than CD117/Sca-1-enriched cells alone. This second enrichment step resulted in an increase in cTnTpositive cells. We also noted that there was a doublet amplicon for the DHPR-α2 subunit in our RT-PCR analysis. The primers used for the PCR did not distinguish between cardiac and skeletal muscle forms of the subunit suggesting that myogenic development for both skeletal and cardiac muscle probably occurred in our cultures.
The presence of calcium channels and ionic currents in undifferentiated bone marrow mesenchymal stem cells has been previously reported [27, 28] . We were able to identify a nifedipine-sensitive isoform of the L-type Ca 2+ channel in cells enriched for the CD117/ Sca-1 cell surface markers and demonstrated that differentiated cells displayed spontaneous Ca 2+ transients. This is the first observation, to our knowledge, in which differentiated BM-MSC displayed persistent One of the most striking findings in our study is that the frequency of the Ca 2+ transients increased over time and that the transient amplitude duration of CD117/Sca-1-enriched cells decreased from 14 to 29 days in culture. Evidence from studies in embryonic-derived cardiomyocytes [16] and developing heart [19, 29] suggests that as the cardiomyocyte matures from neonatal to adult, Ca 2+ entry, storage, and release is altered by synthesis and maturation of SR-Ca 2+ release channels and voltage-sensitive channels. The change in Ca 2+ kinetics observed in our cells over time is consistent with the observed changes in the maturing cardiomyocyte.
In conclusion, we found that differentiating media containing low serum was equally effective in inducing cTnT expression and spontaneous calcium transients compared to the DNA methyltransferase inhibitor, 5-azacytidine. In addition, cTnT expression and spontaneous calcium transients in BM-MSC were more prevalent in IP cells following CD117/Sca-1 enrichment compared to unenriched Lin − cells and variability in the calcium transients decreased as length of time in differentiating media increased. The increase in spontaneous calcium cycling frequency, decrease in transient duration with time, and identification of enriched cells with functional L-type Ca 2+ channels suggests a progressive maturation of the calcium regulatory mechanisms of the cell and thus greater myogenic development. Taken together, these data demonstrate that specific cell enrichment steps and early cardiac lineage development in culture may improve the potential of BM-MSC for regenerative therapy.
